Halliburton has named its latest cohort. Photo via Getty Images

Seven companies from around the world have been invited to join Halliburton Labs, the company announced today.

Halliburton Labs is an incubator program that helps early-stage energy tech companies through connections, access to facilities, and more.

"We are pleased to welcome these promising energy startups and provide customized support to help them achieve their specific priorities, accelerate commercialization, and increase valuation," says Dale Winger, managing director of the program, in a news release. "Our experienced practitioners and network will help these companies use their time and capital efficiently."

The next Halliburton Labs Finalists Pitch Day, which will feature the ongoing cohort, is planned for Thursday, March 14, in New Orleans in coordination with New Orleans Entrepreneur Week and 3rd Coast Venture Summit. Applications for the program are open until Friday, February 9.

The newest additions to Halliburton Labs are as follows.

One of three Israel-based companies in the cohort, Airovation Technologies is advancing carbon capture and utilization solutions through helping hard-to-abate industries that achieve emissions reduction targets through its proprietary carbon mineralization technology. Through transforming point-source CO2 emissions into circular chemicals and building materials, Airovation is developing a scalable pathway for industrial emitters to decarbonize with multiple revenue streams.

“Industrial emitters are seeking economic ways to decarbonize,” Marat Maayan, founder and CEO at Airovation Technologies, says. “We are excited to accelerate our commercialization in the United States with Halliburton Labs, leveraging their expertise, capabilities and network."

Ayrton Energy, based in Calgary, is developing liquid organic hydrogen carrier storage technology to enable the large-scale, efficient transportation of hydrogen over extended distances without hydrogen loss and pipeline corrosion. This storage technology provides a high-density hydrogen storage medium without the need for cryogenics or high-pressure systems, which differs from the existing technology out there. This improves the safety and efficiency of hydrogen storage while enabling the use of existing fuel infrastructure for transportation, including tanks, transport trucks, and pipelines.

“Our mission is to enable hydrogen adoption by solving the key challenges in hydrogen storage and transportation,” Ayrton CEO Natasha Kostenuk says.

Cache Energy, based out of the University of Illinois Research Park, is developing a new long duration energy storage solution, which scales to interseasonal durations, through a low-cost solid fuel. Once charged, the storage material stores energy at room temperature, with near zero loss in time and can be safely stored and transported anywhere energy is needed.

“We are strong believers of leveraging existing infrastructure and expertise to fast track decarbonization goals,” Arpit Dwivedi, founder and, says CEO of Cache Energy. “We look forward to this collaboration and learning from Halliburton's manufacturing and operational expertise, as we scale our technology.”

From Be'er Sheva City in Israel, CENS develops enhanced dry dispersion technology based on dry-treated carbon nanotubes that enable high energy density, high power, and outstanding cycle performance in Li-ion batteries. The technology is differentiated because it can be applied to any type of lithim-ion battery and its implementation can be seamlessly integrated into the production line.

“Our goal is to develop ground-breaking technologies that will become disruptive technologies to market at a massive scale,” says CEO Moshe Johary. “With the help and vast experience of Halliburton Labs' team, we could achieve advancements in production capabilities while extending our footprint in the market.”

Casper, Wyoming-based Disa Technologiesprovides solutions to the mining and remediation industries. Disa utilizes patented minerals liberation technology to more efficiently isolate target minerals and mitigate environmental impacts to its users. Disa platforms treat a wide array of critical minerals that are essential to the economy and our way of life.

“We are excited to have Halliburton's support as we scale-up our technology and deliver innovative minerals processing solutions that disrupt industry best practices, enhance global resource utilization, and benefit the environment and the communities we serve," Greyson Buckingham, Disa's CEO and president, says.

Marel Power Solutions, headquartered from Michigan, is innovating electrification through its novel powerstack technology. These materials-efficient, quickly deployable, and scalable power-stacks, encapsulating advanced cooling technology, redefine power conversion in mobility, industrial, and renewables spaces.

“We're thrilled to contribute to global climate sustainability. Our collaboration with Halliburton will accelerate the electrification transition across industries. Marel's technology not only maximizes heat evacuation from densely packed power semiconductors but, more importantly, offers substantial savings in cost, weight, size, and time, making it transformative in the evolving landscape of electrification,” Marel CEO Amrit Vivekanand says.

And lastly, XtraLit is an Israeli company that develops a technology for direct lithium extraction from brines. The technology enables efficient and economically justified processing of brines even with relatively low lithium concentrations. Application of the extraction technology will allow mineral providers to unlock new significant sources of lithium that are critical to meet growing demand.

“Oil and gas industry produced waters might become a substantial resource for lithium production,” says XtraLit CEO, Simon Litsyn. “XtraLit will cooperate with Halliburton on optimization of produced water treatment for further increasing the efficiency of the lithium extraction process.”

------

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.


Houston researchers make headway on affordable, sustainable sodium-ion battery

Energy Solutions

A new study by researchers from Rice University’s Department of Materials Science and NanoEngineering, Baylor University and the Indian Institute of Science Education and Research Thiruvananthapuram has introduced a solution that could help develop more affordable and sustainable sodium-ion batteries.

The findings were recently published in the journal Advanced Functional Materials.

The team worked with tiny cone- and disc-shaped carbon materials from oil and gas industry byproducts with a pure graphitic structure. The forms allow for more efficient energy storage with larger sodium and potassium ions, which is a challenge for anodes in battery research. Sodium and potassium are more widely available and cheaper than lithium.

“For years, we’ve known that sodium and potassium are attractive alternatives to lithium,” Pulickel Ajayan, the Benjamin M. and Mary Greenwood Anderson Professor of Engineering at Rice, said in a news release. “But the challenge has always been finding carbon-based anode materials that can store these larger ions efficiently.”

Lithium-ion batteries traditionally rely on graphite as an anode material. However, traditional graphite structures cannot efficiently store sodium or potassium energy, since the atoms are too big and interactions become too complex to slide in and out of graphite’s layers. The cone and disc structures “offer curvature and spacing that welcome sodium and potassium ions without the need for chemical doping (the process of intentionally adding small amounts of specific atoms or molecules to change its properties) or other artificial modifications,” according to the study.

“This is one of the first clear demonstrations of sodium-ion intercalation in pure graphitic materials with such stability,” Atin Pramanik, first author of the study and a postdoctoral associate in Ajayan’s lab, said in the release. “It challenges the belief that pure graphite can’t work with sodium.”

In lab tests, the carbon cones and discs stored about 230 milliamp-hours of charge per gram (mAh/g) by using sodium ions. They still held 151 mAh/g even after 2,000 fast charging cycles. They also worked with potassium-ion batteries.

“We believe this discovery opens up a new design space for battery anodes,” Ajayan added in the release. “Instead of changing the chemistry, we’re changing the shape, and that’s proving to be just as interesting.”

---

This story originally appeared on EnergyCapitalHTX.com.